Navigation Links
Breast Growth in Boys Might Be Linked to Plastics Chemical

But it's still too early to say that phthalates actually cause the condition, experts say

TUESDAY, Dec. 15 (HealthDay News) -- Common chemicals found in plastic toys and elsewhere could contribute to the abnormal growth of breasts in boys, preliminary research suggests.

The research, published in a prominent medical journal for pediatricians, adds fuel to the debate over these chemicals, called phthalates, whose safety has been questioned by some scientists. The chemical industry claims the ubiquitous manmade chemicals, which are used to soften plastics and stabilize fragrances, are safe.

The small study only involved a few dozen boys, but if more research confirms that the chemicals boost estrogen levels, as some scientists suspect, then "we need to start thinking about how we can approach chemical policy and chemical regulation so we don't have phthalates causing this effect," said Dr. Sheela Sathyanarayana, an assistant professor of pediatrics at the University of Washington, who is familiar with the study findings.

Phthalates are found in everyday products, including baby toys, plastic wrap, electronics and shower curtains, and in personal care products, such as perfume and shampoo. They're also found in food, since much of what people eat is exposed to plastics.

Some research has linked phthalates to disrupted hormone levels. Most recently, a small study suggested that exposure to phthalates in the womb might make boys more likely to play with toys typically associated with girls, although there were caveats to that research, and a spokesman for the American Chemistry Council dismissed the findings at the time.

In the new study, Turkish researchers tested 40 boys who were newly diagnosed with gynecomastia -- enlarged breasts -- and 21 boys who didn't have the condition. The researchers checked the levels of phthalates-related substances in their blood.

The levels were 2.8 to 25 times higher in the boys with enlarged breasts, said the researchers, who published their findings in the January issue of the journal Pediatrics.

The study does not prove that phthalate exposure leads to enlarged breasts or raises the risk that gynecomastia will occur. And researchers aren't sure why enlarged breasts develop in boys, said study co-author Dr. Elif Ozmert of Hacettepe University in Ankara, Turkey. According to the study, up to 65 percent of teenage boys can have enlarged breasts.

The condition does appear to have something do with estrogen and testosterone, Ozmert said. It could be "an increase in one, decrease in the other or a combination."

If estrogen does increase because of exposure to phthalates, this could affect girls too, possibly leading to early breast development. "The effect is not limited to boys, but the consequences are different for boys and girls," Ozmert said.

Sathyanarayana said another factor could play a role: Those who had enlarged breasts were more likely to have a family history of the condition.

What to do? Larger trials still need to be conducted to confirm or refute the findings. But for now, parents can decrease their exposure to phthalates, in particular by avoiding plastic products labeled with the No. 3, Sathyanarayana said.

And she added the general note that, "as a society, we need to start thinking about whether we want phthalates in general production or not."

Attempts by HealthDay to reach the American Chemistry Council for comment were unsuccessful.

More information

Learn more about gynecomastia from U.S. National Library of Medicine.

SOURCES: Elif Ozmert, M.D., Ph.D., Hacettepe University, Ankara, Turkey; and Sheela Sathyanarayana, M.D., assistant professor of pediatrics, University of Washington, Seattle; January 2010 Pediatrics.

Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Needle Biopsy Works Well in Diagnosing Breast Cancer
2. Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table
3. Study finds racial disparities exist in radiation therapy rates for early stage breast cancer
4. Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy
5. Chemo With Herceptin May Be Best for Some Breast Cancers
6. M. D. Anderson study questions true favorability of rare breast cancer type
7. Antibody-guided drug shows encouraging activity in metastatic breast cancer
8. Tweaks to Breast Cancer Treatments Boost Outcomes
9. Clinical trial advances new approach to re-sensitizing breast cancer
10. Novel detection method unmasks circulating breast cancer cells
11. Targeted therapy prolongs life in patients with HER2-positive breast cancer
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology: